loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2004_317___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Yamasa Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Yamasa Corporation Choshi JP (1)

    filter

    01 Ribavirin (1)

    filter

    01 Japan (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Yamasa Corporation Choshi JP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ribavirin

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2004-317 - Rev 01
    Withdrawn by Holder
    Chemical
    2011-10-14
    2018-02-06
    2109
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-317 - Rev 01 of Yamasa Corporation Choshi Jp

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-317 - Rev 01 of Yamasa Corporation Choshi Jp 1

    20

    Yamasa Corporation Choshi Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Ribavirin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-317 - Rev 01

    This Chemical Type CEP, issued on October 14, 2011, remains in force until February 06, 2018, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2109 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY